查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1923638

个人剂量监测服务市场按设备类型、部署类型、应用和最终用户行业划分 - 全球预测 2026-2032 年

Personal Dose Monitoring Service Market by Device Type, Deployment Mode, Application, End User Industry - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，个人剂量监测服务市场价值将达到 4.693 亿美元，到 2026 年将成长至 5.0883 亿美元，到 2032 年将达到 8.6102 亿美元，复合年增长率为 9.05%。

关键市场统计数据
基准年 2025 4.693亿美元
预计年份：2026年 5.0883亿美元
预测年份 2032 8.6102亿美元
复合年增长率 (%) 9.05%

个人化暴露追踪如何透过持续测量、整合分析和人性化的实施策略重新定义安全措施和临床实践

个人剂量监测已成为职业安全、临床照护和环境管理交叉领域的关键职能。过去十年，技术创新和监管力度的加强显着改变了各机构测量、报告和应对暴露数据的方式。现代系统结合了微型感测器、安全的资料架构和分析功能，能够将原始资料转化为可供现场工作人员和临床团队使用的实用资讯。

识别技术、监管和人性化的趋势的融合点，这些趋势将重塑剂量监测解决方案的策略方向和应用路径。

个人剂量监测领域正经历一系列变革，这些变革是由技术、监管和劳动力趋势的整合所驱动的。首先，感测器性能的提升和低功耗无线连接的广泛应用，使得设备运作更长时间，从而促进其在移动性和隐蔽性至关重要的环境中得到应用。其次，基于云端的分析和边缘运算技术的进步，为监管人员和临床医生提供了近乎即时的风险信息，从而能够更快地进行干预，并缩短从发现到响应的延迟时间。

了解2025年美国关税调整对剂量监测技术部署的采购、供应链韧性与筹资策略的影响

2025年美国生效的关税调整和贸易政策变更将进一步增加个人剂量监测相关技术的采购和供应链规划的复杂性。相关人员报告称，关税税目变更和分类更新加重了跨境运输的行政负担，迫使采购团队重新评估供应商合约和总到岸成本假设。为此，製造商和经销商正在评估替代筹资策略，转移部分生产流程，并更新物流工作流程，以降低关税风险并确保供应连续性。

一种基于细分的详细观点，将设备类别、特定产业要求、部署模式和应用环境与实施和管治选择相匹配。

深入的细分对于根据个人剂量监测的不同应用场景自订功能至关重要。基于设备类型，该生态系统涵盖了基于云端的分析平台（用于聚合和关联暴露数据）、固定监测系统（用于提供基准值）、行动应用程式（允许现场负责人存取警报和历史记录）以及可穿戴设备（为一线工作人员提供个人化、连续的读数）。每类设备在测量精度、覆盖范围和用户操作便利性之间各有优劣，而满足操作需求的最佳配置通常需要结合多种设备类型。

美洲、欧洲、中东和非洲以及亚太地区的采用趋势和策略考量对采购、整合和商业化的影响

区域趋势影响个人剂量监测技术的应用、监管要求和伙伴关係模式。在美洲，成熟的法规结构、医疗服务提供者的集中以及对职业安全的高度重视，推动了综合监测方案的早期应用。在采购方面，倾向于选择能够与现有电子健康记录和职业健康系统互通性的解决方案。该地区的跨境贸易以及与大型製造地的接近性也影响供应商的选择和物流规划。

如何透过感测器创新、整合分析、监管能力和服务主导的市场推广模式来建立竞争优势

个人剂量监测领域的主要企业正从多个维度进行差异化竞争，包括感测器精度、资料架构、法规遵循支援以及涵盖安装、校准和持续分析的端到端服务。一些供应商专注于硬体创新，致力于缩小尺寸和延长电池续航时间，以实现隐藏、长期佩戴。另一些供应商则专注于平台功能，提供基于角色的仪錶板、自动化报告和基于云端的分析功能，并配备API接口，以便轻鬆整合到职业健康管理系统和临床资讯系统中。

实际的实施和管治步骤，帮助领导者将监测试点项目转化为可扩展的项目，从而提升安全性、营运效率和临床品质。

产业领导者应采取策略性的分阶段方法，以最大限度地发挥个人剂量监测技术的价值。首先，明确定义与临床或营运目标相符的应用情境和成功指标，确保所选设备和分析方法与这些目标直接相关。试点计画应进行范围界定，以检验与现有IT系统的集成，并评估使用者在正常运作条件下的接受度。在试点阶段密切关注人为因素，将有助于减少规模化推广时的阻力。

结合相关人员访谈、标准审查和情境分析的混合方法、证据驱动型方法，为实施者提供可操作且检验的见解。

本分析的调查方法整合了第一手和第二手研究证据，旨在对趋势和影响进行平衡且可重复的评估。第一手资料包括对来自国防、医疗保健、核能以及石油和天然气行业的技术高管、采购负责人和合规专业人员进行的结构化访谈。这些访谈旨在了解组织在实施监测专案时面临的实际应用经验、采购考量和营运权衡。

概述综合监测专案如何从合规工具转变为安全、临床洞察和环境管理的策略驱动力

总之，个人剂量监测正处于一个转折点，技术成熟度、不断演进的法规以及相关人员的期望汇聚在一起，共同推动更积极主动的暴露管理。当设备、分析和管治三者融合，能够提供精准的测量结果、及时的警报以及与临床和营运工作流程的无缝整合时，其最具吸引力的价值提案便会显现。那些将监测定位为一项程序化能力，并辅以清晰的指标、强有力的管治和迭代式变更管理的机构，将从中获得最大的利益。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 依设备类型分類的个人剂量监测服务市场

  • 基于云端的分析
  • 固定监控系统
  • 行动应用
  • 穿戴式装置

9. 依部署模式分類的个人剂量监测服务市场

  • 基于云端的
  • 本地部署

第十章：按应用分類的个人剂量监测服务市场

  • 环境监测
    • 空气品质
    • 水污染
  • 病患监测
    • 癌症治疗监测
    • 诊断放射学
  • 研究与开发
    • 学术研究
    • 临床试验
  • 工人安全
    • 工业检验
    • 放射科

第十一章：以最终用户产业分類的个人剂量监测服务市场

  • 防御
    • 边防安全
    • 军事设施
  • 卫生保健
    • 诊断影像中心
    • 医院
  • 核能发电
    • 发电厂
    • 研究所
  • 石油和天然气
    • 探勘现场
    • 炼油厂

12. 各地区个人剂量监测服务市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章 个人剂量监测服务市场（依群体划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

14. 各国个人剂量监测服务市场

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

15. 美国个人剂量监测服务市场

第十六章：中国个人剂量监测服务市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Atomtex SPE
  • Berthold Technologies GmbH & Co. KG
  • Canberra Industries, Inc.
  • Fluke Biomedical
  • Fuji Electric Co., Ltd.
  • Global Dosimetry Solutions, Inc.
  • IBA Dosimetry GmbH
  • Landauer, Inc.
  • Ludlum Measurements, Inc.
  • Mirion Technologies, Inc.
  • Nuvia Dynamics
  • Panasonic Holdings Corporation
  • Polimaster, Inc.
  • Prosys, Inc.
  • Radiation Detection Company, Inc.
  • RadPro International GmbH
  • SE International, Inc.
  • Thermo Fisher Scientific Inc.
  • TSI Incorporated
  • Unfors Raysafe AB
Product Code: MRR-867BED9AA0B6

The Personal Dose Monitoring Service Market was valued at USD 469.30 million in 2025 and is projected to grow to USD 508.83 million in 2026, with a CAGR of 9.05%, reaching USD 861.02 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 469.30 million
Estimated Year [2026] USD 508.83 million
Forecast Year [2032] USD 861.02 million
CAGR (%) 9.05%

How personalized exposure tracking is redefining safety and clinical practice through continuous measurement, integrated analytics, and human-centered deployment strategies

Personal dose monitoring has emerged as a critical capability at the intersection of occupational safety, clinical care, and environmental stewardship. Over the last decade, technological innovation and heightened regulatory scrutiny have transformed how organizations measure, report, and act on exposure data. Contemporary systems combine miniaturized sensors, secure data architectures, and analytics that translate raw readings into actionable insights for frontline workers and clinical teams alike.

The move from episodic sampling to continuous, individualized monitoring reflects a broader shift toward preventive risk management. In healthcare settings, for example, the ability to track cumulative exposure for patients undergoing multiple imaging procedures enhances treatment planning and supports informed consent. In industrial environments, wearable devices and mobile applications provide real-time alerts that reduce acute incidents and support long-term occupational health strategies. Consequently, investment decisions now weigh integration potential as heavily as sensor performance, with interoperability and user experience becoming decisive factors.

As this introduction underscores, the value of personal dose monitoring lies not only in measurement accuracy but in the system's capacity to connect people, processes, and data. Organizations that align technology selection with clear operational objectives and governance frameworks are best positioned to move beyond compliance and achieve measurable improvements in safety, cost control, and stakeholder trust.

Identifying converging technological, regulatory, and human-centered trends that are reshaping the strategic direction and adoption pathways for dose monitoring solutions

The landscape for personal dose monitoring is undergoing a series of transformative shifts driven by converging technological, regulatory, and workforce trends. First, sensor performance improvements and the proliferation of low-power wireless connectivity have enabled devices to operate for longer durations with minimal user burden, fostering adoption in settings where mobility and unobtrusiveness are essential. Second, advances in cloud-based analytics and edge processing bring near-real-time risk intelligence to supervisors and clinicians, enabling faster interventions and reducing latency between detection and response.

Regulatory frameworks are evolving to reflect these technological capabilities. Agencies are clarifying expectations around data provenance, calibration, and reporting, which raises the bar for vendor compliance while creating opportunities for products that emphasize traceability and auditability. At the same time, organizational priorities are shifting from episodic compliance checks to continuous exposure management programs that combine monitoring, training, and process redesign.

Finally, the human factor is central to these shifts. Systems that prioritize user experience, privacy-preserving data handling, and clear communication of risk are gaining traction. As a result, vendors and adopters are rethinking deployment strategies to foreground worker acceptance, clinical workflow compatibility, and change management. Taken together, these dynamics are steering the market toward integrated solutions that deliver measurable operational and clinical benefits rather than stand-alone sensing hardware.

Understanding how the 2025 United States tariff adjustments are reshaping procurement, supply-chain resilience, and sourcing strategies for dose monitoring technology deployments

Tariff changes and trade policy adjustments in the United States for 2025 have introduced additional complexity into procurement and supply-chain planning for technologies tied to personal dose monitoring. Stakeholders report that altered tariff lines and classification updates have increased the administrative burden for cross-border shipments, prompting procurement teams to revisit vendor contracts and total landed cost assumptions. In response, manufacturers and distributors are evaluating alternative sourcing strategies, relocating certain manufacturing steps, and updating logistics workflows to mitigate tariff exposure and ensure continuity of supply.

These adjustments also influence product design choices, as some vendors reassess the geographic footprint of component sourcing to preserve cost competitiveness. Meanwhile, procurement cycles are lengthening where decision-makers seek greater clarity on duty liabilities and customs compliance before finalizing large-scale deployments. For smaller adopters and those with limited procurement capacity, the unpredictability introduced by tariff shifts can delay pilots and reduce the scope of initial rollouts.

Regulatory coordination between customs authorities and standard-setting bodies is emerging as a critical enabler for smoother trade flows. Organizations with proactive trade-compliance capabilities and flexible supplier relationships are in a better position to manage near-term volatility. Strategically, the combined effect of these tariff-related dynamics is to elevate the importance of supply-chain resilience, local partnership networks, and contract terms that explicitly address cross-border duties and regulatory changes.

Detailed segmentation-driven perspectives that align device classes, industry-specific requirements, deployment modes, and application contexts to implementation and governance choices

Insightful segmentation is essential to match capabilities to the diverse use cases for personal dose monitoring. Based on device type, the ecosystem spans cloud-based analytics platforms that aggregate and contextualize exposure data, fixed monitoring systems that provide area-based baselines, mobile applications that enable field personnel to access alerts and historical records, and wearable devices that deliver individualized, continuous readings for frontline workers. Each device class brings trade-offs between granularity, coverage, and user burden, and the optimal configuration often combines multiple device types to meet operational needs.

Based on end user industry, adoption patterns and procurement drivers vary significantly across defense, healthcare, nuclear power, and oil and gas. Within defense, the primary focus areas include border security and military installations where durability, cybersecurity, and chain-of-custody for exposure data are paramount. Healthcare settings prioritize diagnostic imaging centers and hospitals, where patient monitoring for cumulative exposure during cancer therapy monitoring and diagnostic radiology is a key use case. Nuclear power stakeholders include power plants and research institutions that require rigorous calibration standards and integrated environmental monitoring. Oil and gas operators deploy monitoring across exploration sites and refineries, emphasizing worker safety under challenging environmental conditions.

Based on deployment mode, organizations evaluate cloud-based solutions for their scalability and remote management benefits versus on-premise deployments that offer tighter control over sensitive data and localized analytics. Based on application, the domain of use extends to environmental monitoring, patient monitoring, research and development, and worker safety. Environmental monitoring splits into air quality and water contamination applications that inform broader public health initiatives, while patient monitoring encompasses cancer therapy monitoring and diagnostic radiology needs that tie directly to clinical decision pathways. Research and development users span academic research and clinical trials, each demanding rigorous data integrity and reproducibility standards. Worker safety applications focus on industrial inspection and radiology workflows where real-time alerts, incident logging, and post-exposure follow-up are operational priorities.

Taken together, these segmentation lenses reveal that solution design, procurement strategy, and post-deployment governance must be tailored not only to technical requirements but to the organizational culture, regulatory constraints, and use-case-specific workflows that drive adoption and value realization.

Regional adoption dynamics and strategic considerations across the Americas, Europe Middle East & Africa, and Asia-Pacific that influence procurement, integration, and commercialization

Regional dynamics shape technology adoption, regulatory expectations, and partnership models for personal dose monitoring. In the Americas, mature regulatory frameworks, a concentration of healthcare providers, and a strong emphasis on occupational safety support early adoption of integrated monitoring programs; procurement often favors solutions that demonstrate interoperability with existing electronic health records and occupational health systems. Cross-border trade within the region and proximity to large manufacturing bases also influence supplier selection and logistics planning.

In Europe, Middle East & Africa, heterogeneous regulatory environments and diverse healthcare infrastructures mean that deployments must be highly adaptable. Western European markets tend to prioritize data protection, device certification, and integration with national health systems, whereas markets in other parts of the region may focus on ruggedized devices and cost-effective deployment models suitable for resource-constrained settings. Partnerships with regional integrators and local service providers are often decisive in these geographies.

Asia-Pacific displays a wide spectrum of adoption stages, from highly digitized healthcare ecosystems to rapidly industrializing markets requiring scalable, low-cost solutions. The region's manufacturing capacity and supply-chain agility support rapid prototyping and localized production, which can reduce lead times and enhance customization. Across all regions, interoperability, compliance with local standards, and culturally informed user engagement strategies are critical to accelerating adoption and ensuring sustainable program outcomes.

How competitive differentiation is being crafted through sensor innovation, integrated analytics, regulatory competence, and service-driven go-to-market models

Leading companies in the personal dose monitoring space are differentiating along several dimensions: sensor fidelity, data architecture, regulatory compliance support, and end-to-end services that include installation, calibration, and ongoing analytics. Some vendors concentrate on hardware innovation, advancing miniaturization and battery life to enable unobtrusive long-term wear. Others emphasize platform capabilities, offering cloud-based analytics with role-based dashboards, automated reporting, and APIs that facilitate integration with occupational health and clinical information systems.

Collaborative partnerships between device manufacturers, software providers, and systems integrators are becoming more common as customers demand turnkey solutions that span procurement, deployment, and maintenance. Value-added services such as training, accreditation support, and longitudinal exposure analysis are increasingly part of vendor propositions. Companies that can demonstrate rigorous quality management systems, clear calibration and traceability processes, and strong post-sales support tend to secure larger institutional contracts because they reduce implementation risk and support compliance.

Competitive positioning is also shaped by go-to-market models: some firms prioritize direct sales to large healthcare systems and industrial operators, while others leverage distribution networks and channel partners to reach smaller customers and geographically dispersed sites. Ultimately, leading organizations balance product innovation with service excellence and regulatory competence to meet the diverse needs of clinical, defense, nuclear, and industrial customers.

Actionable deployment and governance steps for leaders to convert monitoring pilots into scalable programs that deliver safety, operational efficiency, and clinical quality

Industry leaders should take a strategic, phased approach to capture the most value from personal dose monitoring technologies. First, start with a clear articulation of use cases and success metrics that align with clinical or operational objectives, ensuring the selection of devices and analytics that map directly to those outcomes. Pilots should be scoped to validate integration with existing IT systems and to assess user acceptance under normal operating conditions; careful attention to human factors during pilots reduces friction during scale-up.

Second, prioritize interoperability and data governance. Select solutions that offer standardized interfaces and strong data provenance capabilities to simplify integration with electronic health records, occupational health platforms, and incident management systems. Robust governance frameworks that define data ownership, retention, and access controls will protect sensitive exposure data and support regulatory compliance.

Third, invest in supply-chain resilience and contractual safeguards. Given the changing trade and tariff environment, contracts should explicitly address duties, warranties, service-level expectations, and parts availability. Build relationships with regional partners to shorten lead times and provide local support. Finally, create a change management plan that includes training, communication of value to frontline users, and mechanisms for feedback-driven iteration. By combining rigorous technical evaluation with attention to organizational adoption, leaders can transform monitoring from a compliance obligation into a strategic capability that improves safety, operational efficiency, and clinical quality.

A mixed-methods, evidence-driven approach combining stakeholder interviews, standards review, and scenario analysis to produce actionable and verifiable insights for implementers

The research methodology underpinning this analysis combines primary and secondary evidence to produce a balanced, reproducible assessment of trends and implications. Primary inputs include structured interviews with technical leaders, procurement officers, clinical users, and compliance specialists across defense, healthcare, nuclear, and oil and gas sectors. These interviews were designed to capture real-world deployment experiences, procurement considerations, and the operational trade-offs organizations encounter when implementing monitoring programs.

Secondary inputs consist of a systematic review of technical standards, regulatory guidance, product literature, and peer-reviewed studies related to sensor performance, data integrity, and exposure management practices. The methodology emphasizes triangulation, cross-referencing statements from interviews with documented standards and published technical evaluations to validate claims about performance, interoperability, and use-case fit. Where appropriate, scenario analysis was used to explore the implications of supply-chain disruptions and regulatory changes on procurement timelines and deployment risk.

Quality assurance measures include validation of technical claims against calibration and certification documentation, and peer review of findings by domain experts. The approach intentionally focuses on practical adoption barriers and enablers rather than hypothetical market sizing, ensuring the analysis is actionable for practitioners planning pilots, procurement, and scale-up.

Concluding synthesis on how integrated monitoring programs can transition from compliance tools to strategic enablers of safety, clinical insight, and environmental stewardship

In conclusion, personal dose monitoring stands at an inflection point where technological maturity, regulatory evolution, and stakeholder expectations are converging to enable more proactive exposure management. The most compelling value propositions arise when devices, analytics, and governance converge to deliver accurate readings, timely alerts, and seamless integration with clinical and occupational workflows. Organizations that treat monitoring as a programmatic capability-supported by clear metrics, robust governance, and iterative change management-will realize the greatest benefits.

Near-term success will depend on pragmatic decisions: selecting device mixes that balance granularity with usability, choosing deployment modes that respect data sensitivity, and building supplier relationships that mitigate supply-chain uncertainty. For public and private entities alike, the ability to demonstrate traceability, data integrity, and user-centered design will be central to achieving stakeholder buy-in. As adoption grows, the focus should shift from isolated implementations to longitudinal exposure management strategies that inform training, preventive maintenance, and clinical decision-making.

Ultimately, the path forward favors integrative thinking: aligning technology choices with organizational goals, regulatory requirements, and the human realities of frontline users. When executed thoughtfully, personal dose monitoring can move from a compliance instrument to a strategic enabler of safer workplaces, more informed clinical care, and improved environmental stewardship.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Personal Dose Monitoring Service Market, by Device Type

  • 8.1. Cloud-Based Analytics
  • 8.2. Fixed Monitoring Systems
  • 8.3. Mobile Applications
  • 8.4. Wearable Devices

9. Personal Dose Monitoring Service Market, by Deployment Mode

  • 9.1. Cloud-Based
  • 9.2. On-Premise

10. Personal Dose Monitoring Service Market, by Application

  • 10.1. Environmental Monitoring
    • 10.1.1. Air Quality
    • 10.1.2. Water Contamination
  • 10.2. Patient Monitoring
    • 10.2.1. Cancer Therapy Monitoring
    • 10.2.2. Diagnostic Radiology
  • 10.3. Research And Development
    • 10.3.1. Academic Research
    • 10.3.2. Clinical Trials
  • 10.4. Worker Safety
    • 10.4.1. Industrial Inspection
    • 10.4.2. Radiology

11. Personal Dose Monitoring Service Market, by End User Industry

  • 11.1. Defense
    • 11.1.1. Border Security
    • 11.1.2. Military Installations
  • 11.2. Healthcare
    • 11.2.1. Diagnostic Imaging Centers
    • 11.2.2. Hospitals
  • 11.3. Nuclear Power
    • 11.3.1. Power Plants
    • 11.3.2. Research Institutions
  • 11.4. Oil And Gas
    • 11.4.1. Exploration Sites
    • 11.4.2. Refineries

12. Personal Dose Monitoring Service Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Personal Dose Monitoring Service Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Personal Dose Monitoring Service Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Personal Dose Monitoring Service Market

16. China Personal Dose Monitoring Service Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Atomtex SPE
  • 17.6. Berthold Technologies GmbH & Co. KG
  • 17.7. Canberra Industries, Inc.
  • 17.8. Fluke Biomedical
  • 17.9. Fuji Electric Co., Ltd.
  • 17.10. Global Dosimetry Solutions, Inc.
  • 17.11. IBA Dosimetry GmbH
  • 17.12. Landauer, Inc.
  • 17.13. Ludlum Measurements, Inc.
  • 17.14. Mirion Technologies, Inc.
  • 17.15. Nuvia Dynamics
  • 17.16. Panasonic Holdings Corporation
  • 17.17. Polimaster, Inc.
  • 17.18. Prosys, Inc.
  • 17.19. Radiation Detection Company, Inc.
  • 17.20. RadPro International GmbH
  • 17.21. S.E. International, Inc.
  • 17.22. Thermo Fisher Scientific Inc.
  • 17.23. TSI Incorporated
  • 17.24. Unfors Raysafe AB

LIST OF FIGURES

  • FIGURE 1. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY DEVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY DEPLOYMENT MODE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY END USER INDUSTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES PERSONAL DOSE MONITORING SERVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA PERSONAL DOSE MONITORING SERVICE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY CLOUD-BASED ANALYTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY CLOUD-BASED ANALYTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY CLOUD-BASED ANALYTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY FIXED MONITORING SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY FIXED MONITORING SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY FIXED MONITORING SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY MOBILE APPLICATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY MOBILE APPLICATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY MOBILE APPLICATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY WEARABLE DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY WEARABLE DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY WEARABLE DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY CLOUD-BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY CLOUD-BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY CLOUD-BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY ON-PREMISE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY ON-PREMISE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY ON-PREMISE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY ENVIRONMENTAL MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY ENVIRONMENTAL MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY ENVIRONMENTAL MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY AIR QUALITY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY AIR QUALITY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY AIR QUALITY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY WATER CONTAMINATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY WATER CONTAMINATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY WATER CONTAMINATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY PATIENT MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY PATIENT MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY PATIENT MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY PATIENT MONITORING, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY CANCER THERAPY MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY CANCER THERAPY MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY CANCER THERAPY MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY DIAGNOSTIC RADIOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY DIAGNOSTIC RADIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY DIAGNOSTIC RADIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY RESEARCH AND DEVELOPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY RESEARCH AND DEVELOPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY RESEARCH AND DEVELOPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY ACADEMIC RESEARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY ACADEMIC RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY ACADEMIC RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY CLINICAL TRIALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY CLINICAL TRIALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY CLINICAL TRIALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY WORKER SAFETY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY WORKER SAFETY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY WORKER SAFETY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY WORKER SAFETY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY INDUSTRIAL INSPECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY INDUSTRIAL INSPECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY INDUSTRIAL INSPECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY RADIOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY RADIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY RADIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY END USER INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY DEFENSE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY DEFENSE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY DEFENSE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY DEFENSE, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY BORDER SECURITY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY BORDER SECURITY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY BORDER SECURITY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY MILITARY INSTALLATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY MILITARY INSTALLATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY MILITARY INSTALLATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY HEALTHCARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY HEALTHCARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY HEALTHCARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY NUCLEAR POWER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY NUCLEAR POWER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY NUCLEAR POWER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY NUCLEAR POWER, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY POWER PLANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY POWER PLANTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY POWER PLANTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY RESEARCH INSTITUTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY RESEARCH INSTITUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY OIL AND GAS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY OIL AND GAS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY OIL AND GAS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY OIL AND GAS, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY EXPLORATION SITES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY EXPLORATION SITES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY EXPLORATION SITES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY REFINERIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY REFINERIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY REFINERIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 105. AMERICAS PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 106. AMERICAS PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 107. AMERICAS PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 108. AMERICAS PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 109. AMERICAS PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 110. AMERICAS PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY PATIENT MONITORING, 2018-2032 (USD MILLION)
  • TABLE 111. AMERICAS PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 112. AMERICAS PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY WORKER SAFETY, 2018-2032 (USD MILLION)
  • TABLE 113. AMERICAS PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY END USER INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 114. AMERICAS PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY DEFENSE, 2018-2032 (USD MILLION)
  • TABLE 115. AMERICAS PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 116. AMERICAS PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY NUCLEAR POWER, 2018-2032 (USD MILLION)
  • TABLE 117. AMERICAS PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY OIL AND GAS, 2018-2032 (USD MILLION)
  • TABLE 118. NORTH AMERICA PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. NORTH AMERICA PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 120. NORTH AMERICA PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 121. NORTH AMERICA PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 122. NORTH AMERICA PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY PATIENT MONITORING, 2018-2032 (USD MILLION)
  • TABLE 124. NORTH AMERICA PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 125. NORTH AMERICA PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY WORKER SAFETY, 2018-2032 (USD MILLION)
  • TABLE 126. NORTH AMERICA PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY END USER INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 127. NORTH AMERICA PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY DEFENSE, 2018-2032 (USD MILLION)
  • TABLE 128. NORTH AMERICA PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 129. NORTH AMERICA PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY NUCLEAR POWER, 2018-2032 (USD MILLION)
  • TABLE 130. NORTH AMERICA PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY OIL AND GAS, 2018-2032 (USD MILLION)
  • TABLE 131. LATIN AMERICA PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. LATIN AMERICA PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. LATIN AMERICA PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 134. LATIN AMERICA PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 135. LATIN AMERICA PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 136. LATIN AMERICA PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY PATIENT MONITORING, 2018-2032 (USD MILLION)
  • TABLE 137. LATIN AMERICA PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 138. LATIN AMERICA PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY WORKER SAFETY, 2018-2032 (USD MILLION)
  • TABLE 139. LATIN AMERICA PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY END USER INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 140. LATIN AMERICA PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY DEFENSE, 2018-2032 (USD MILLION)
  • TABLE 141. LATIN AMERICA PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 142. LATIN AMERICA PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY NUCLEAR POWER, 2018-2032 (USD MILLION)
  • TABLE 143. LATIN AMERICA PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY OIL AND GAS, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE, MIDDLE EAST & AFRICA PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY PATIENT MONITORING, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY WORKER SAFETY, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY END USER INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY DEFENSE, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY NUCLEAR POWER, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY OIL AND GAS, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPE PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPE PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY PATIENT MONITORING, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPE PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPE PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY WORKER SAFETY, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPE PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY END USER INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPE PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY DEFENSE, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPE PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPE PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY NUCLEAR POWER, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPE PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY OIL AND GAS, 2018-2032 (USD MILLION)
  • TABLE 170. MIDDLE EAST PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 171. MIDDLE EAST PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 172. MIDDLE EAST PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 173. MIDDLE EAST PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 174. MIDDLE EAST PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 175. MIDDLE EAST PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY PATIENT MONITORING, 2018-2032 (USD MILLION)
  • TABLE 176. MIDDLE EAST PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 177. MIDDLE EAST PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY WORKER SAFETY, 2018-2032 (USD MILLION)
  • TABLE 178. MIDDLE EAST PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY END USER INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 179. MIDDLE EAST PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY DEFENSE, 2018-2032 (USD MILLION)
  • TABLE 180. MIDDLE EAST PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 181. MIDDLE EAST PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY NUCLEAR POWER, 2018-2032 (USD MILLION)
  • TABLE 182. MIDDLE EAST PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY OIL AND GAS, 2018-2032 (USD MILLION)
  • TABLE 183. AFRICA PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 184. AFRICA PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 185. AFRICA PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 186. AFRICA PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 187. AFRICA PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 188. AFRICA PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY PATIENT MONITORING, 2018-2032 (USD MILLION)
  • TABLE 189. AFRICA PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 190. AFRICA PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY WORKER SAFETY, 2018-2032 (USD MILLION)
  • TABLE 191. AFRICA PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY END USER INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 192. AFRICA PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY DEFENSE, 2018-2032 (USD MILLION)
  • TABLE 193. AFRICA PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 194. AFRICA PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY NUCLEAR POWER, 2018-2032 (USD MILLION)
  • TABLE 195. AFRICA PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY OIL AND GAS, 2018-2032 (USD MILLION)
  • TABLE 196. ASIA-PACIFIC PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 197. ASIA-PACIFIC PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 198. ASIA-PACIFIC PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 199. ASIA-PACIFIC PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 200. ASIA-PACIFIC PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 201. ASIA-PACIFIC PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY PATIENT MONITORING, 2018-2032 (USD MILLION)
  • TABLE 202. ASIA-PACIFIC PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 203. ASIA-PACIFIC PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY WORKER SAFETY, 2018-2032 (USD MILLION)
  • TABLE 204. ASIA-PACIFIC PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY END USER INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 205. ASIA-PACIFIC PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY DEFENSE, 2018-2032 (USD MILLION)
  • TABLE 206. ASIA-PACIFIC PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 207. ASIA-PACIFIC PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY NUCLEAR POWER, 2018-2032 (USD MILLION)
  • TABLE 208. ASIA-PACIFIC PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY OIL AND GAS, 2018-2032 (USD MILLION)
  • TABLE 209. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 210. ASEAN PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 211. ASEAN PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 212. ASEAN PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 213. ASEAN PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 214. ASEAN PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 215. ASEAN PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY PATIENT MONITORING, 2018-2032 (USD MILLION)
  • TABLE 216. ASEAN PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 217. ASEAN PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY WORKER SAFETY, 2018-2032 (USD MILLION)
  • TABLE 218. ASEAN PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY END USER INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 219. ASEAN PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY DEFENSE, 2018-2032 (USD MILLION)
  • TABLE 220. ASEAN PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 221. ASEAN PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY NUCLEAR POWER, 2018-2032 (USD MILLION)
  • TABLE 222. ASEAN PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY OIL AND GAS, 2018-2032 (USD MILLION)
  • TABLE 223. GCC PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 224. GCC PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 225. GCC PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 226. GCC PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 227. GCC PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 228. GCC PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY PATIENT MONITORING, 2018-2032 (USD MILLION)
  • TABLE 229. GCC PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 230. GCC PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY WORKER SAFETY, 2018-2032 (USD MILLION)
  • TABLE 231. GCC PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY END USER INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 232. GCC PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY DEFENSE, 2018-2032 (USD MILLION)
  • TABLE 233. GCC PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 234. GCC PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY NUCLEAR POWER, 2018-2032 (USD MILLION)
  • TABLE 235. GCC PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY OIL AND GAS, 2018-2032 (USD MILLION)
  • TABLE 236. EUROPEAN UNION PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 237. EUROPEAN UNION PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 238. EUROPEAN UNION PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 239. EUROPEAN UNION PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 240. EUROPEAN UNION PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 241. EUROPEAN UNION PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY PATIENT MONITORING, 2018-2032 (USD MILLION)
  • TABLE 242. EUROPEAN UNION PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 243. EUROPEAN UNION PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY WORKER SAFETY, 2018-2032 (USD MILLION)
  • TABLE 244. EUROPEAN UNION PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY END USER INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 245. EUROPEAN UNION PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY DEFENSE, 2018-2032 (USD MILLION)
  • TABLE 246. EUROPEAN UNION PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 247. EUROPEAN UNION PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY NUCLEAR POWER, 2018-2032 (USD MILLION)
  • TABLE 248. EUROPEAN UNION PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY OIL AND GAS, 2018-2032 (USD MILLION)
  • TABLE 249. BRICS PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 250. BRICS PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 251. BRICS PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 252. BRICS PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 253. BRICS PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 254. BRICS PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY PATIENT MONITORING, 2018-2032 (USD MILLION)
  • TABLE 255. BRICS PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 256. BRICS PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY WORKER SAFETY, 2018-2032 (USD MILLION)
  • TABLE 257. BRICS PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY END USER INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 258. BRICS PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY DEFENSE, 2018-2032 (USD MILLION)
  • TABLE 259. BRICS PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 260. BRICS PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY NUCLEAR POWER, 2018-2032 (USD MILLION)
  • TABLE 261. BRICS PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY OIL AND GAS, 2018-2032 (USD MILLION)
  • TABLE 262. G7 PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 263. G7 PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 264. G7 PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 265. G7 PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 266. G7 PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 267. G7 PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY PATIENT MONITORING, 2018-2032 (USD MILLION)
  • TABLE 268. G7 PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 269. G7 PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY WORKER SAFETY, 2018-2032 (USD MILLION)
  • TABLE 270. G7 PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY END USER INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 271. G7 PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY DEFENSE, 2018-2032 (USD MILLION)
  • TABLE 272. G7 PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 273. G7 PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY NUCLEAR POWER, 2018-2032 (USD MILLION)
  • TABLE 274. G7 PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY OIL AND GAS, 2018-2032 (USD MILLION)
  • TABLE 275. NATO PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 276. NATO PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 277. NATO PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 278. NATO PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 279. NATO PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 280. NATO PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY PATIENT MONITORING, 2018-2032 (USD MILLION)
  • TABLE 281. NATO PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 282. NATO PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY WORKER SAFETY, 2018-2032 (USD MILLION)
  • TABLE 283. NATO PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY END USER INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 284. NATO PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY DEFENSE, 2018-2032 (USD MILLION)
  • TABLE 285. NATO PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 286. NATO PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY NUCLEAR POWER, 2018-2032 (USD MILLION)
  • TABLE 287. NATO PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY OIL AND GAS, 2018-2032 (USD MILLION)
  • TABLE 288. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 289. UNITED STATES PERSONAL DOSE MONITORING SERVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 290. UNITED STATES PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 291. UNITED STATES PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032